PAMEX pramipexole dihydrochloride 0.125 mg tablets blister pack

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Kupite ga zdaj

Javno poročilo o oceni Javno poročilo o oceni (PAR)
26-11-2017

Aktivna sestavina:

pramipexole dihydrochloride monohydrate, Quantity: 0.125 mg

Dostopno od:

Arrotex Pharmaceuticals Pty Ltd

INN (mednarodno ime):

pramipexole dihydrochloride monohydrate

Farmacevtska oblika:

Tablet, uncoated

Sestava:

Excipient Ingredients: silicon dioxide; pregelatinised maize starch; povidone; mannitol; magnesium stearate

Pot uporabe:

Oral

Enote v paketu:

10, 30, 100

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

Povzetek izdelek:

Visual Identification: White, circular, flat, beveled edged uncoated tablets debossed with 'CL' on one side and '2' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status dovoljenje:

Licence status A

Datum dovoljenje:

2014-09-23